Recent studies have indicated impaired endotheliumdependent relaxation in arteries of insulin-dependent [1] diabetic (IDDM) patients. The mechanisms for this defect in human blood vessels is not yet understood. Several studies have observed defects in endothelium-dependent relaxation in both conduit and resistance arteries of streptozotocin (STZ)-or alloxaninduced diabetic rats or rabbits (see reviews [2, 3] ).
Summary We examined the effects of acute supplementation with arginine in vitro on endothelium-dependent relaxation in aortic rings taken from female genetic, diabetes-prone BB rats. Sensitivity to norepinephrine-induced contraction was unaltered in rings of diabetic BB rats compared to rings from non-diabetic littermates. In precontracted rings, acetylcholine produced a concentration-dependent relaxation which was impaired by diabetes. This relaxation was blocked by l -arginine had no effect on acetylcholine-induced relaxation in control rings. In contrast, relaxation-induced by nitroglycerin in diabetic rings without endothelium was not altered by l -arginine treatment. Thus, a defect in the utilization of arginine by nitric oxide synthase exists in the endothelium of the diabetic BB rat. [Diabetologia (1997) 
40: 910-915]
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housed for 2 months prior to evaluation of endothelial function.
At the termination of the study, animals were anaesthetized with sodium pentobarbital (65 mg/kg, i. p.). Blood samples were collected from unfasted animals for determination of blood glucose using ExacTech glucometer and test strips (Medisense Inc., Cambridge, Mass., USA.) and for total glycosylated haemoglobin using a commercial diagnostic kit (Sigma Diagnostics, St. Louis, Mo., USA). Descending thoracic aortae were carefully excised and excessive connective tissue and fat were removed. Segments of aorta were cut into rings and mounted on parallel wires in 10 ml isolated Radnoti tissue baths containing Krebs-Henseleit media as previously described [6] . Rings were contracted to an optimal resting tension of 2.0 g and equilibrated for 1 h. Isometric tension was measured using Radnoti force-displacement transducers and amplifiers connected to a Gould TA6000 recorder.
Concentration-response curves to norepinephrine were performed. After challenge to norepinephrine, each ring was serially washed with fresh medium and equilibrated for 45 min. Rings were then contracted with a submaximal concentration of norepinephrine (e. g. 1 m mol/l) which produced approximately 60-65 % maximal response. At the plateau of contraction, concentration-dependent relaxation to acetylcholine (ACH) or nitroglycerin (NTG) was used to evaluate endothelium-dependent compared to endothelium-independent dilation, respectively. In some rings relaxation to ACH was repeated in rings without intervention or after pretreatment for 20 min with 100 Statistical analysis. Data (presented as the mean ± SEM with n = individual animals) was analysed by analysis of variance followed by Newman Keuls or unpaired t-and paired t-test, where appropriate. A value of p less than 0.05 was set to denote statistical significance.
Results
A total of 13 diabetic and 11 non-diabetic rat littermates were used for this study. At the conclusion of the study, non-diabetic rats weighed 237 ± 4 g while diabetic rats weighed 213 ± 6 g. Blood glucose concentration was significantly (p < 0.001) elevated in diabetic rats (13.7 ± 1.7 mmol/l) compared to non-diabetic rats (3.7 ± 0.7 mmol/l). Total glycosylated haemoglobin was significantly (p < 0.01) elevated (i. e. 4.7 ± 0.4 and 2.3 ± 0.3 %, respectively).
There was no significant difference (p > 0.05) in either maximal tension development or sensitivity to norepinephrine between non-diabetic and diabetic rings. For example, pD 2 (-log EC 50 ) was 6.5 ± 0.1 for both groups. Using a submaximal norepinephrine concentration of 1 m mol/l for the relaxation studies, the percentage maximum response was not different between non-diabetic (67 ± 4 %) and diabetic (65 ± 2 %) rings.
ACH produced a concentration-dependent relaxation in both non-diabetic and diabetic rings. This Diabetic (n = 13) * * ( * * * ) ( * * * ) ( * * * ) ( * * * ) ( * ) ( * ) * * * * * Fig. 1 . Endothelium-dependent relaxation to acetylcholine in aortic rings of diabetic BB rat compared to rings from non-diabetic littermates. Also shown is the response in a subset of rings pretreated with 100 m mol/l l -nitroarginine (l-NA). *p < 0.05 and **p < 0.01 vs untreated diabetic and *p < 0.05 and ***p < 0.001 vs corresponding untreated rings relaxation was blocked by pretreatment with l -NA in both groups. The ACH-induced relaxation was significantly reduced in rings taken from diabetic animals ( Fig. 1) . In rings without endothelium, NTG-induced relaxation was unaltered by diabetes ( Fig. 2) . While l -ARG had no effect on relaxation to ACH in control rings (Fig. 3 ), l -ARG enhanced the relaxation to ACH in diabetic rings (Fig. 4) . In contrast,
d
-ARG did not alter relaxation to ACH in diabetic rings. For example maximum relaxation to ACH was 55 ± 7 and 57 ± 7 % (first and second challenge to ACH), 51 ± 3 and 80 ± 2 % (before and after l -ARG) and 59 ± 6 and 65 ± 5 % (before and after d -ARG). Maximum relaxation was 82 ± 6 and 79 ± 5 % in control rings without or with ARG-treatment.
Addition of l -ARG to diabetic rings without endothelium did not modify the relaxation produced by NTG (Fig. 5 ). Pretreatment with l -ARG had no effect on the contractile response to norepinephrine prior to challenge with ACH (e. g. untreated diabetic = 2.04 ± 0.13 g; l -ARG-treated diabetic = 1.97 ± 0.11 g).
Discussion
Significant evidence exists for defective endotheliumdependent relaxation in chemically induced diabetic models. In contrast, very little information is available regarding the existence or nature of this dysfunction in the genetic diabetic BB rats. Two early reports [4, 5] indicated impaired endothelium-dependent relaxation to ACH but not to the endothelium-independent vasodilators, sodium nitroprusside or nitrite, in aortic rings of chronically diabetic BB rats. Our results in the present study and elsewhere [6] confirm the impairment of endothelium-dependent but not endothelium-independent relaxation to NTG in this model.
Similarly, a more recent report has demonstrated impaired relaxation to both ACH and bradykinin in mesenteric resistance vessels in recent-onset, spontaneously diabetic BB/Wistar rats [7] . Taken together this suggests that the phenomenon occurs in both conduit and resistance blood vessels in this model. One potential limitation of all the three other studies using the BB rat model is that there is no indication whether evaluations were conducted using male or female animals or whether results reflect observations derived from animals of mixed gender. While we have observed that defective endothelium- dependent relaxation can be observed in both male and female diabetic BB rats; we have noted that the onset of dysfunction occurs earlier in time in females compared to males (G Pieper, unpublished observations). Thus, we chose female diabetic BB rats and non-diabetic littermates for our study.
Despite the two original studies showing impaired endothelium-dependent relaxation in diabetic BB rat aorta, no one has yet addressed the specific nature of impaired endothelium-dependent relaxation in conduit arteries of the spontaneously diabetic BB rat. Our study is the first to demonstrate the efficacy of l -ARG to reverse defective endothelium-dependent relaxation in aorta of the genetic diabetic BB rat suggesting a defect in the effective utilization of ARG for synthesis of NO by the diabetic endothelium in this model. This effect was demonstrated to be specific for diseased blood vessels in that l -ARG failed to enhance ACH-induced relaxation in aorta taken from non-diabetic littermates. Furthermore, this action is stereospecific in that the d -ARG stereoisomer was ineffective.
It is unlikely that the increased relaxation to ACH in l -ARG-treated diabetic aorta can be explained by an increased sensitivity of guanylate cyclase activity of diabetic vascular smooth muscle to NO since NTG-induced relaxation of diabetic aorta without endothelium was not altered. Furthermore, since the contractile response to norepinephrine was not altered in diabetic aorta exposed to l -ARG, this argues against a direct dilator activity of l -ARG contributing to enhanced endothelium-dependent relaxation. Finally, since we previously demonstrated that aminoguanidine, an inhibitor of inducible NO synthase, does not alter responses in aorta of the BB rat [5] , the enhanced ACH-induced relaxation of diabetic aorta by l -ARG is unlikely to be explained by providing substrate for NO by any putative inducible NO synthase present in diabetic vascular smooth muscle.
Our observation showing improvement in endothelium-dependent relaxation of diabetic BB rat aorta by l -ARG is consistent with previous studies conducted in our laboratory in which acute administration of l -ARG in vitro normalized the defective relaxation to ACH in aorta taken from STZ-induced diabetic Sprague-Dawley and Lewis strain rats [8, 9] . The observation that l -ARG did not enhance relaxation in aorta of rats of longer diabetes duration [9] suggests that the mechanism of dysfunction might vary with duration of disease. The salient effect of l -ARG has also been recently shown in coronary arteries of the alloxan-induced diabetic dog evaluated in vivo [10] and in normal mesenteric arteries exposed in vitroto elevated glucose concentrations [11] . Taken together these results suggest that a defect in ARG utilization by endothelial NO synthase for NO production is independent of the model of diabetes.
It has been suggested that endothelial dysfunction in any diabetic model evaluated in vitro reflects the fact that l -ARG is generally absent in the buffer used in organ bath experiments [12] . We find this to be an over simplification for several reasons. First, if endothelial dysfunction were merely due to an absence of ARG in the buffer, one should logically expect diminished relaxation to all endothelium-dependent vasodilators which release NO. This is not the case since the responses to the receptor-independent, endothelium-dependent vasodilator, calcium ionophore, are not altered in aorta of either STZ-induced [8] or genetically induced diabetic BB rats [6] . Secondly, while information in BB vascular tissue is not available, we have shown that the ARG content in freshly extracted aorta derived from the STZ-induced diabetic rat is already significantly reduced [13] . Thirdly, it is noteworthy that l -ARG can improve function both in vitro and in vivo and that the addition of ARG can improve relaxation in diabetic canine coronaries in vivo despite no significant reduction in plasma ARG concentration. This suggests that diabetes-induced impaired endothelium-dependent relaxation is not likely due merely to an artifact of ex vivo evaluation and that defects in ARG conversion to NO might occur even under conditions of normal extracellular ARG concentration.
Despite the beneficial effects of l -ARG administration given both in vitro and in vivo on endothelium-dependent relaxation in various diabetic models, a recent study revealed that l -ARG did not improve relaxation to ACH in mesenteric arteries of the spontaneously diabetic BB rat [7] . Since no information was provided regarding insulin dosages, glucose levels and glycosylated haemoglobin in the mesenteric artery study, it is possible that there was tighter glycaemic control compared to our own study. Alternatively, because of variation in experimental design including disease duration, it is not possible to conclude with certainty that the mechanism of endothelial dysfunction differs between conduit and resistance vessels in the spontaneously diabetic BB rat. Accordingly, direct proof for this hypothesis requires a rigorous study of various types of blood vessels conducted in the same laboratory under similar experimental conditions and at similar durations of disease.
One complication when making any comparison between different vascular beds is the observation that l -NA only partially inhibited relaxation to ACH in mesenteric preparations suggesting that a major component of ACH-induced relaxation in normal mesenteric arteries is not mediated by NO. In contrast, the impaired relaxation to ACH in mesenteric arteries of newly onset BB rats and those chronically treated with insulin was completely abolished using l -NA [7] . This observation suggests that the ACH-induced relaxation of mesenteric arteries in these two groups is completely mediated by NO and that diabetes elicits a compensatory increase in the NO-dependent portion of relaxation in this model. In this situation the addition of l -ARG might not be expected to improve relaxation.
The additional observation that indomethacin enhanced relaxation to ACH in diabetic mesenteric rings suggests that an overlapping increased production of vasoconstrictor prostanoids contributes to endothelial dysfunction. Thus, it is likely that any putative defects which are specific for altered ARG utilization in mesenteric preparations from diabetic BB rats may be difficult to evaluate due to the masking by other vasoactive factors. While this does not diminish the potential importance of other vasoactive factors contributing to relaxation in this preparation, it considerably complicates any direct analysis of diabetes-induced defects in relaxation which are specific for NO. In contrast, we have shown that ACH-induced relaxation in aorta of both non-diabetic and diabetic BB rat are likely to be entirely mediated by NO since relaxations were blocked using l -NA and that this relaxation in both groups is insensitive to alteration by indomethacin [6] suggesting that defective ACH-induced relaxation in this model can be explained without the complications of alterations in vasoactive prostanoids.
A more plausible explanation for the divergent observations regarding the efficacy of ARG in the diabetic BB rat is due to a combination of incubation time and ARG concentration. For example, in the mesenteric artery study [7] , blood vessels were exposed for a relatively short period of time (i. e. 20 min) compared to the 45 min duration in our study. In this regard, it has been demonstrated in ARG-deprived bovine aortic endothelial cells incubated with 10 m mol/l extracellular ARG that a minimum of at least 50 min is required to replete intracellular ARG to steady-state concentrations [14] . The extracellular concentration of ARG used in the mesenteric study was 10 m mol/l (i. e. 300 times lower than that used in our study). This low concentration is nearly 20 times lower than the physiological plasma ARG concentration of approximately 200 m mol/l reported in our laboratory [8, 9, 15] and elsewhere [16] in different strains of rats and from 7-to 10-times lower than the plasma ARG concentration in STZ-induced diabetic rats. Furthermore, ARG transport into tissue would not be expected to be anywhere near saturation since 10 m mol/l ARG is approximately 10 times lower than the K m for transport by endothelial cells reported to be near 100 m mol/l [17] . Thus, under these experimental conditions, it could reasonably be predicted that the addition of 10 m mol/l ARG might not have any significant impact on endothelial function in these diabetic mesenteric artery preparations. Because of all of these variances, we believe it prudent at this time to caution any extrapolation of the mechanism of endothelial dysfunction in conduit arteries to mechanisms in resistance arteries and vice versa.
The results obtained in the present study using supplementation with l -ARG suggest that deficits in NO production may account for this defect in diabetic BB rat aorta. This conclusion is consistent with recent studies using coronary microvascular endothelial cells isolated from diabetic BB rats in which decreased basal NO production was observed from intact cells based upon measurements of both nitrate/ nitrite production and ARG-to-citrulline conversion and this could not be accounted for by any intrinsic defects in ARG transporter [18] . In contrast, direct measurement of NO synthase activity in cell homogenates under optimal conditions indicated that there was no intrinsic defect in the NO synthase enzyme in diabetic BB rat endothelial cells. This suggests that decreased production of NO is specific for intact endothelial cells. This could potentially result from either a limitation in the utilization of the substrate, ARG, either by supply or compartmentalization or limitation in a cofactor for NO synthase, or both, contributing to decreased NO production by diabetic BB rat endothelium. Thus, the mechanism of the salient effect of l -ARG on impaired endothelium-dependent relaxation in diabetic blood vessels is likely due to enhanced NO production.
In summary, our experiments provide new information regarding the nature of the defect in endothelium-dependent relaxation in this important experimental model of human IDDM. Our results suggest that a defect exists in efficient utilization of ARG for synthesis of NO by NO synthase in the diabetic BB rat endothelium and that supplementation with the substrate, ARG, may be one means to reverse endothelial dysfunction.
